Management Team
- Full-spectrum expertise
- PhD & postdoctoral research collective
- Rooted in top-tier universities
- Average age in 30s — dynamic & driven
- High-performance R&D unit
Wenlin Huang, M.D., Ph.D.
Chairman & Chief Scientist
Shuo Tian, Ph.D.
Chief Executive Officer
Liutao Zhai, Ph.D.
Deputy General Manager
Jian Wang, Ph.D.
Deputy General Manager
Team Gallery
Passion, collaboration, and scientific excellence
24th Anniversary · Doublle Biologics
2025 Spring Festival Gathering
Outdoor Retreat & Team Building
×
Wenlin Huang, M.D., Ph.D.
Founder & Chairman | Expert in Oncology & Virology
Profile
- National Distinguished Expert, recipient of State Council Special Allowance.
- Top 10 Overseas Returnee Scholars in Guangzhou; Innovation & Entrepreneurship Leader.
- Professor at Sun Yat-sen University Cancer Center; Honorary Professor at The Chinese University of Hong Kong.
- Former Senior Research Fellow at Princeton University.
- Rotating Chair of Asia-Pacific Cell & Gene Therapy Association.
- Vice Director of Gene Therapy Division, China Medicinal Biotech Association.
- Published nearly 200 papers; Elsevier China Highly Cited Researcher (2020).
×
Shuo Tian, Ph.D.
Chief Executive Officer
Biography
- Expertise in tumor immunology and molecular mechanisms.
- Participated in multiple National Natural Science Foundation projects.
- Published SCI papers in journals including Autophagy, Cell Research, etc.
- Leads IND filings for biologics (oncology drugs, vaccines) and immune cell products.
×
Liutao Zhai, Ph.D.
Deputy General Manager
Scientific Leadership
- Ph.D. in Biochemistry and Molecular Biology.
- Editor-in-Chief of "Cell & Anti-Aging New Tech" WeChat public account.
- Deputy Secretary-General of Guangdong Anti-Aging Research Association.
- Expert member of Cell & Gene Therapy Committee, International Society of Translational Medicine.
- First to resolve high-resolution crystal structure of yeast telomerase reverse transcriptase (TERT).
- Focuses on anti-cancer drug discovery targeting telomerase, immune cells, stem cells and their derivatives.
- Author of multiple SCI papers in Nucleic Acids Research, Biochemical Journal, etc. Holds several patents.
×
Jian Wang, Ph.D.
Deputy General Manager
Research & Experience
- Postdoctoral fellow at the Wistar Institute (USA), served over 20 years at the Academy of Military Medical Sciences.
- Research focus: molecular mechanisms of tumor progression, targeted therapies, and preclinical oncology drug evaluation.
- Principal investigator of two National Natural Science Foundation projects; mentored multiple graduate students.
- Published 21 SCI papers; currently leads oncolytic virus drug discovery programs.